Trending news

Konstantin Linnik Weighs in on Ramifications of Sequenom v. Ariosa in Intellectual Property Magazine

Print PDF

Konstantin Linnik, Ph.D., a partner in Nutter's Intellectual Property Department and Life Sciences practice group, discussed the ramifications of the patent case Sequenom v. Ariosa, currently pending petition for review by the U.S. Supreme Court, in Intellectual Property Magazine. Nutter filed an amicus brief on behalf of a group of biotech industry associations which urges the Supreme Court to reconsider the interpretation of patentable subject matter under 35 USC 101 and argues that the current approach hinders investment in the development of new diagnostics and life-saving medicines. In the article, “Pharma rallies behind Sequenom to battle patent ‘erosion’,” Konstantin, a co-author of the brief, noted, “The current U.S. jurisprudence puts the U.S. out of sync with the rest of the industrialised world. It effectively deprives the emerging field of personalised medicine of any IP protection in the U.S., while most other countries are taking a different approach.”

More News >
Back to Page